Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food […]
Research Presented at RDD 2021 Suggests That Acoustic Technology Is a Viable Alternative to High-cost Electronic Smart Inhalers
Research presented at the Respiratory Drug Delivery (RDD) 2021 conference suggests that inhalers using acoustic […]
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate (NanoFlu/NVX-CoV2373)
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]
MATWIN Highlights Four Innovative Projects in the Fight Against Cancer
MATWIN, the French oncology accelerator and subsidiary of Unicancer, today announces the four winners chosen […]
Pfizer and BioNTech Initiate BLA for FDA Approval of Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application […]
‘Never Done Before’ AI Study Could Improve Early Detection of Pancreatic Cancer
Artificial intelligence (AI) could potentially be used to aid early diagnosis of pancreatic cancer and […]
Abbott New Trial Seeks Better Treatment for AFib and Heart Failure
Abbott (NYSE: ABT) today announced a new trial focused on improving the treatment for people simultaneously […]
Viome Receives FDA Approval for its Unique mRNA Technology and AI Platform to Detect Cancers
Viome, a mission-driven bioscience company focused on helping individuals improve their health, today announced its […]
UK Medicines Regulator Issues its First Authorisation Under Project Orbis
A post-surgery treatment for lung cancer will be the first to receive an authorisation from […]
Statement from Gates Foundation CEO Mark Suzman
The Bill & Melinda Gates Foundation has been working urgently since January 2020 with a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more